Objectives:
¢ºTo provide an opportunity of both international exchange of academic interests in pharmacokinetics/pharmacodynamics (PK/PD) areas and dissemination of up-to-date methodologies to pharmaceutical people
¢ºTo discuss the latest developments in PK/PD modeling & simulation and its applications in drug development, regulatory decision and clinical practice
Topics:
¢ºNovel concepts in clinical pharmacology (PK/PD)
¢ºBiomarkers, Surrogate endpoints
¢ºDetection and prediction of drug efficacy and safety
¢ºSubject compliance
¢ºDisease model
¢ºOptimization of dosage regimen design
¢ºRole of regulation agency
¢ºModeling and simulation in drug development, regulatory decision and clinical applications
|